Somerset Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-16,974
Closed -$1.05M 196
2014
Q4
$1.05M Sell
16,974
-132
-0.8% -$7.53K 0.7% 47
2014
Q3
$889K Sell
17,106
-17,703
-51% -$903K 0.62% 56
2014
Q2
$1.79M Sell
34,809
-411
-1% -$18.5K 1.27% 27
2014
Q1
$1.67M Sell
35,220
-939
-3% -$48.1K 1.27% 25
2013
Q4
$1.57M Buy
+36,159
New +$1.5M 1.19% 28

Other funds holding XBI

Somerset Trust's XBI Position: Q1 2015 in Review

Somerset Trust sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2015, closing a stake of 16,974 shares — an estimated $1.05M sold.

Somerset Trust first reported a position in XBI in Q4 2013 and held it in 5 quarters. The position peaked at $1.79M in Q2 2014. 180 funds tracked by Wall St. Rank hold XBI as of Q1 2015.

  • Somerset Trust reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2015 after selling out during the quarter.
  • Somerset Trust sold 16,974 State Street SPDR S&P Biotech ETF shares in Q1 2015, an estimated $1.05M.
  • Somerset Trust first reported a position in State Street SPDR S&P Biotech ETF in Q4 2013 and held it in 5 quarters.
  • Somerset Trust's State Street SPDR S&P Biotech ETF position peaked at $1.79M in Q2 2014.
  • 180 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2015.

Based on Somerset Trust's 13F filing for Q1 2015, filed 16 Apr 2015.